Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ketorolac Trometamol
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Ache Laboratorios Farmaceuticos SA
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Nemera's multidose eye dropper Novelia® has been approved by ANVISA for the preservative-free formulations CLILON (Ketorolac 0,4% and 0,5%), a nonsteroidal anti-inflammatory drug that is used to treat moderately severe pain and inflammation, usually aft...
Product Name : Clilon
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 05, 2021
Lead Product(s) : Ketorolac Trometamol
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Ache Laboratorios Farmaceuticos SA
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
